发明名称 RNA interference mediated inhibition of protein tyrosine phosphatase type IVA (PRL3) gene expression using short interfering nucleic acid (siNA)
摘要 This invention relates to compounds, compositions, and methods useful for modulating protein tyrosine phosphatase type IVA (PRL3) gene expression using short interfering nucleic acid (siNA) molecules. This invention also relates to compounds, compositions, and methods useful for modulating the expression and activity of other genes involved in pathways of protein tyrosine phosphatase type IVA (PRL3) gene expression and/or activity by RNA interference (RNAi) using small nucleic acid molecules. In particular, the instant invention features small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (mRNA), and short hairpin RNA (shRNA) molecules and methods used to modulate the expression of protein tyrosine phosphatase type IVA (PRL3) genes.
申请公布号 US2005176663(A1) 申请公布日期 2005.08.11
申请号 US20040897902 申请日期 2004.07.23
申请人 SIMA THERAPEUTICS, INC. 发明人 MCSWIGGEN JAMES;BEIGELMAN LEONID;USMAN NASSIM
分类号 A61K38/00;A61K47/48;C07H21/02;C12N15/11;C12N15/113;C12N15/115;C12N15/87;(IPC1-7):A61K48/00 主分类号 A61K38/00
代理机构 代理人
主权项
地址